This AI Just Got Certified to Help Doctors Spot What Humans Miss During Endoscopies
DUBLIN, IRELAND 4TH MAY, 2025,– Cosmo Pharmaceuticals N.V. announced today that Endovision Limited has won certification from the EU MDR for Cerebro, its cutting-edge AI software that provides guidance for real-time esophagogastroduodenoscopy (EGD) procedures.
Positioned now on this major regulatory milestone, Cerebro comes into play as one of the first Computer-Assisted Quality (CAQ) tools for endoscopy that works to standardize upper GI procedures and reduce variability and improve patient outcomes.
Saurabh Jejurikar, CEO of Endovision Limited, commented:
“Achieving MDR certification underscores our team’s ability to innovate, develop, and secure approval for groundbreaking AI solutions.”
Regarding the collaboration with Cosmo, he added:
“I’m proud of making available our product in the most advanced real-time AI ecosystem available today. Building on top of it, we are now leading the way toward a new era of standardization through Computer-Aided Quality (CAQ) in endoscopy.”
“It is exciting to see how our ecosystem is reducing the barriers to the adoption of responsible AI into clinical practice,”
Said Nhan Ngo Dinh, President of Cosmo Intelligent Medical Devices. He added:
“This is a perfect example of how software-defined medical devices can change the pace of innovation and, simultaneously, demonstrates once more the effectiveness of our strategy to translate Artificial Intelligence into real patient benefits.”
Cerebro will debut later this year on Cosmo’s AI Access™ platform, incorporated into the Medtronic GI Genius™intelligent endoscopy system.
It will be powered by deep learning to assist physicians in identifying crucial landmarks through different imaging modalities-WL, NBI, TXI, and BLI-along with producing automated documentation and quality scoring.
Cerebro is a product of the collaboration with CUHK’s Faculty of Medicine and has been designed by the leading AI-and endoscopy specialists.
The application, according to Prof. Philip Chiu and Prof. Yuichi Mori successfully eliminated blind spots, improved visualization, and provided a more comprehensive diagnostic route through slow, guided movement of the endoscope.
Prof. Philip Chiu, Dean of the Faculty of Medicine at CUHK and a leading pioneer in the field of endoscopy, AI, and early diagnosis, shared,
“it is deeply rewarding to see this technology evolve from my initial concept to clinical translation with the potential to significantly improve patient outcomes.”
Highlighting the system’s precision, Dr. Yuichi Mori, Professor at the Faculty of Medicine, University of Oslo, and a leading figure in the advancement of early diagnosis and AI-driven endoscopic technologies, stated:
“Cerebro assists endoscopists in navigating all key landmark points in the upper GI tract, ensuring a comprehensive and thorough examination without blind spots. The system operates with exceptional accuracy when the endoscope is maneuvered slowly, allowing for clear visualization of the landmarks, which ultimately enhances the quality of endoscopy. I am excited to witness how AI-driven technologies like this continue to improve patient care through improved endoscopy quality.”
From lower GI diagnostics, Cosmo’s AI ecosystem now encompasses the whole spectrum of endoscopic care, stretching responsible AI adoption and transforming how physicians relate with live imaging data.
CrowdStrike Unveils Agentic AI Innovations for Next-Gen SOC
Sonata Software Wins $73M AI-Led Digital Deal with US TMT Giant
